These products have not been tested in large, randomized clinical trials, may vary in strength or purity, and may not even contain the same active ingredient as FDA-approved semaglutide, said Fatima Cody Stanford, MD, MPH, an obesity medicine specialist at Massachusetts General Hospital and Harvard Medical School, both in Boston
The IBD Paradox Heres the ultimate paradox
The increased dosage used in Wegovy has been carefully tested and shown to safely promote more substantial reductions in body weight, making it an ideal option for aesthetic patients looking for effective solutions to improve their appearance, confidence, and overall health
Tirzepatide, a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, has shown promise in the treatment of type 2 diabetes and obesity
J Am Acad Child Adolesc Psychiatry
Rare side effects include mild cramping at the injection site or temporary bloating